These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25532408)

  • 1. [Systematic report on re-evaluating kudiezi injection].
    Liao X; Hua GQ; Xie YM; Liu DH
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3626-9. PubMed ID: 25532408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic report on re-evaluating parenterally administered salvianolate].
    Liao X; Xu XY; Xie YM; Chang YP
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3645-9. PubMed ID: 25532413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Literature review on premarketing and postmarketing evidence of xiyanping injection].
    Wang ZF; Chen X; Zhang W; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3637-40. PubMed ID: 25532411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Literature review report on safety evaluation about Kudiezi injection].
    Liao X; Shen H; Xie YM; Zhang W; Yang W; Lv ZG
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2786-8. PubMed ID: 23285934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Literature review report on efficacy evaluation about Kudiezi injection].
    Liao X; Shen H; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2810-3. PubMed ID: 23285941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of questionable allergic factors to kudiezi injection--nested case control study using hospital information system data].
    Liao X; Zeng XB; Xie YM; Yang W; Ai QH
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3559-62. PubMed ID: 25532395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systematic review of Kudiezi injection drug safety].
    Gao SS; Cui RZ; Xie YM; Liao X; Gao XY; Wang JD
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2380-2390. PubMed ID: 28822197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effect of Kudiezi injection on renal function based on propensity score.
    Zhang ZK; Yang W; Liu H; Zeng XB; Zhuang Y; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(13):2661-7. PubMed ID: 26697696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcomes research on data analysis from hospital information system about Kudiezi injection].
    Liao X; Zeng XB; Xie YM; Yang H; Zhuang Y; Chang YP
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2723-6. PubMed ID: 23285919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To establish a body of evidence on safety for postmarketing Chinese medicine: A new research paradigm.
    Liao X; Xie YM; Robinson N; Wang YY
    Chin J Integr Med; 2017 Mar; 23(3):226-232. PubMed ID: 27900605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of kudiezi injection different dosage impact on patient's liver and kidney function based on hospital information system].
    Liao X; Tang H; Xie YM; Yang W; Ai QH
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3585-92. PubMed ID: 25532401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical outcomes research on parenterally administered kudiezi in treatment of cerebral infarction].
    Chang YP; Li L; Xie YM; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3155-60. PubMed ID: 24471344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
    Ai QH; Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxical research of Kudiezi injection in safety re-evaluation].
    Li ZQ; Zhan J; Chang YP; Wang XY; Li SH; Yan YY; Wei HL
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2828-30. PubMed ID: 23285946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke].
    Ye X; Wei X; Xie Y; Zou Y; Zhao X; Han J; Wang X; Ma Y; Bi Q; Xie Q; Zhao J; Cao X; Chen H; Wang S; Yan R; Han Z; Yi D; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2793-5. PubMed ID: 22292367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Building safety evidence body of shuxuetong injection].
    Jiang JJ; Liao X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3630-2. PubMed ID: 25532409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research and practice about risk control of shenfu injection].
    Wang ZF; Tian DL; Zhang W; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3641-4. PubMed ID: 25532412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protocol of intensive hospital monitoring with long follow up and large sample: Diemailing Kudiezi injection as example].
    Liao X; Xie YM; Wang GQ
    Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(24):4494-4499. PubMed ID: 28936829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use propensity score method to analyze data about effectiveness of coronary heart disease treated by kudiezi injection].
    Liao X; Zeng XB; Xie YM; Yang W; Yang W
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3172-9. PubMed ID: 24471347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Kudiezi injection's security literature].
    Chang YP; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2800-3. PubMed ID: 23285938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.